Fast and Secure Delivery Worldwide Express & Expedited Shipping Service
USD $322.60
IndiaOlaparib, marketed under the brand name Lynparza, is a targeted therapy used in the treatment of certain types of cancer, particularly those associated with BRCA mutations. It is classified as a PARP inhibitor, which works by interfering with the cancer cell's ability to repair its DNA, leading to cell death.
The typical dosage of Olaparib is 300 mg taken twice daily. It is important to follow the prescribing physician's instructions and to not exceed the recommended dose. Dosage may vary based on individual patient factors and specific cancer types.
Common side effects of Olaparib may include:
Patients should report any severe or persistent side effects to their healthcare provider.
Olaparib is specifically indicated for patients with certain types of cancer that have BRCA mutations. It is not suitable for all cancer types.
Olaparib should be taken orally, with or without food. It is important to take it at the same time each day to maintain consistent levels in the body.
Patients should inform their healthcare provider of all medications they are taking, as some drugs may interact with Olaparib.
